Looks back at how lung cancer responds to chemotherapy before surgery
Reviews past records of adults with stage IIIA lung cancer given platinum chemotherapy before surgery.
Plain-language title generated from the registry record
Registry title: Pathological Response After Neoadjuvant Treatment on NSCLC
Key facts
- Where
- A Coruña, Alicante, Badalona, Barakaldo, Barcelona, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Madrid, Majadahonda, Málaga, Valencia, and Vigo, SpainSee the 17 sites
Where in Spain
- Hospital Universitario de A CorunaA Coruña, SpainTaking people
- Hospital General Universitario de AlicanteAlicante, SpainTaking people
- ICO Badalona, Hospital Germans Trias i PujolBadalona, SpainTaking people
- Hospital Universitario CrucesBarakaldo, SpainTaking people
- Hospital de la Santa Creu i Sant PauBarcelona, SpainTaking people
- Hospital Vall d'HebronBarcelona, SpainTaking people
- ICO HospitaletL'Hospitalet de Llobregat, SpainTaking people
- Hospital Dr. NegrínLas Palmas de Gran Canaria, SpainTaking people
- Hospital Universitario Insular de Gran CanariaLas Palmas de Gran Canaria, SpainTaking people
- Hospital 12 de OctubreMadrid, SpainTaking people
- Hospital Clínico San CarlosMadrid, SpainTaking people
- Hospital Universitario Fundación Jiménez DíazMadrid, SpainTaking people
- Hospital Universitario La PazMadrid, SpainTaking people
- Hospital Universitario Puerta de HierroMajadahonda, SpainTaking people
- Hospital Universitario Regional de MálagaMálaga, SpainTaking people
- Hospital Universitario la FeValencia, SpainTaking people
- Complejo Hospitalario Universitario de VigoVigo, SpainTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fundación GECP
- Trial code
- NCT05167487
- Record updated
- 6 February 2026
- Original description
This is a non-interventional, observational, multicenter and retrospective study. Being limited to the collection of patient data already filled in the Tumor Thoracic Registry data base and the data from stage IIIA clinical trials case report forms.Read full original descriptionShow less
Retrospective Observational Study of Resectable Stage IIIA Non-small Cell Lung Cancer Patients: Pathological Response After Neoadjuvant Treatment and Patient Outcomes
This is a non-interventional, observational, multicenter and retrospective study. Being limited to the collection of patient data already filled in the Tumor Thoracic Registry data base and the data from stage IIIA clinical trials case report forms.
Inclusion: Patients with resectable stage IIIA disease (according to American Joint Committee on Cancer [AJCC] lung cancer edition 7 or 8) who were included in the Tumor Thoracic Registry data base and in stage IIIA clinical trials which the sponsor is Fundación GECP; Patients with histologically N2 involvement confirmed; Patients diagnosed as stage IIIA from 2010 and 2017; Patients who have received neoadjuvant platinum-based treatment and surgery; Age ≥ 18 years at time of study entry; PET /TC at diagnosis.
Exclusion: Patients who received chemoradiotherapy neoadjuvant treatment; Patients who were not resected after neoadjuvant treatment; Patients who were diagnosed after June 2017.